Finland· FI-REL-REL45840
EVOTAZ
A atazanavir and cobicistat product containing atazanavir sulphate + cobicistat, registered in Finland by Bristol-Myers Squibb Pharma EEIG. The same ATC class is registered in 11 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Atazanavir and cobicistat is registered in 11 of 19 countries.
Countries holding a registration under ATC J05AR15 (atazanavir and cobicistat), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 7 of them publish a price we can compare per daily dose
Atazanavir and cobicistat · ATC J05AR15
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Spainprice
- United Kingdom
- United Statesprice
The record
At a glance
Fimea (Finland)- Active substance
- Atazanavir sulphate + Cobicistat
- Manufacturer
- Bristol-Myers Squibb Pharma EEIG
- Country
- Finland (FI)
- ATC code
- J05AR15
- ATC class
- Atazanavir and cobicistat
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Atazanavir and cobicistat in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaEVOTAZBristol-Myers Squibb Pharma EEIG, Dublin
- SpainEVOTAZ 300 MG/150 MG COMPRIMIDOS RECUBIERTOS CON PELICULABristol-Myers Squibb Pharma Eeig
- United KingdomEvotaz 300mg/150mg tabletsBristol-Myers Squibb Pharmaceuticals Ltd
- IrelandEVOTAZ 300 mg/150 mg film-coated tabletsBristol-Myers Squibb Pharma EEIG
- IcelandEvotazBristol-Myers Squibb Pharma EEIG*
- NetherlandsEVOTAZ 300 mg/150 mg filmomhulde tablettenBristol-Myers Squibb Pharma EEIG
- PolandEvotazBristol-Myers Squibb Pharma EEIG
- SwedenEVOTAZ 300 mg/150 mg Filmdragerad tablettBristol-Myers Squibb Pharma EEIG
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Evotaz
- Liechtenstein · Evotaz
- Norway · Evotaz
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/afa2a5f8-ee8c-4d61-8c7a-9990c769957b GET /v1/drugs/afa2a5f8-ee8c-4d61-8c7a-9990c769957b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "1",
"form": "tabletti, kalvopäällysteinen",
"route": "Suun kautta",
"ddd_unit": "ED",
"strength": "300 mg / 150 mg",
"atc_label": "atatsanaviiri ja kobisistaatti",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/1/15/1025/001-002",
"fimea_rel_id": "REL45840",
"authorised_at": "2015-07-13"
}See everything about atazanavir and cobicistat.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.